Xeris Biopharma (XERS) 2026 Growth Story (Thesis)
Автор: Pharma Phanboi
Загружено: 2026-02-17
Просмотров: 148
Описание:
In this video, I detail my valuation methodology and research for Xeris Biopharma (XERS), why I believe the company is currently undervalued, and why the upcoming Q4 2025 earnings call will serve as the catalyst which will partially eliminate the Margin of Safety.
For more research like this, follow me on X: @PharmaPhanboi
The information provided is for informational purposes only and is not intended as personal financial advice.
There is an inherent risk involved with financial decisions, and these decisions are the sole responsibility of each individual, not the provider of the information.
Certain information herein are estimates/projections, and are not intended to be taken as facts nor guarantees.
You should obtain independent financial advice before making any investment decisions based on the information provided.
Повторяем попытку...
Доступные форматы для скачивания:
Скачать видео
-
Информация по загрузке:
